ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2025
Application of bundle of care for spontaneous intracerebral hemorrhage in the real world: effect on hematoma expansion and functional outcome.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBundle care has recently been the topic of expert consensus statements for optimal management of ICH. The aim of the present study was to assess the application of each intervention of these bundles of care and their combination in the real world and their effect on functional outcome and hematoma expansion.
methodsWe analyzed data from 273 patients with spontaneous ICH who were consecutively admitted to AOUI Verona between January 2022 and June 2024. The components of the bundle of care were the following: (A) door-to-reversal agent administration ≤ 60 min, (B) systolic blood pressure (SBP) target (≤ 140 mmHg), (C) blood glucose (BG) target (108-140 mg/dL in non-diabetic patients and 140-180 mg/dL in diabetic patients), and 4) body temperature (BT) target (≤ 37,5 °C) ≤ 60 min. The primary endpoint was 3-month mRS 0-2. Secondary endpoints were the following: (a) 3-month mortality, (b) 24-hour severe hematoma expansion, (c) 3-month mRS 0-2 in survivors.
resultsBP target (≤ 140 mmHg) ≤ 60 min was associated with higher rate of mRS 0-2 (aOR:4.795; 95% CI:1.343-17.120; p = 0.016) (third model of adjustment for unbalanced variables), lower rate of severe hematoma expansion (aOR:0.254, 95% CI:0.070-0.928; p = 0.038) and higher rate of mRS 0-2 in survivors (aOR:4.445; 95% CI:1.358-13.548; p = 0.014), and BG target ≤ 60 min was associated with lower rate of mortality (aOR:0.290, 95% CI:0.088-0.948; p = 0.041) (adjustment for pre-defined variables).
conclusionsEarly intensive SBP control is the most effective intervention of the bundle of care for improving functional outcomes and reducing hematoma expansion. Early intensive BG control is effective in reducing mortality.
Indexed as
Identifiers
40407993What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.